VYNE updates corporate presentation with previously announced Phase 1a data for VYN202

VYNE Therapeutics Inc.

Phase 1a data for VYN202 and pipeline program updates included in presentation; data was previously announced.
Presentation posted on company website and filed as Exhibit 99.1 on January 13, 2025.
No new financial results or material events disclosed in this 8-K filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.